跳至主要内容
临床试验/ITMCTR1900002404
ITMCTR1900002404招募中1 期

Prospective clinical study for Yuyang Capsule combined with HAART to promote immune reconstitution and delay of AIDS period based on thought of

Sichuan Provincial Administration of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1. Aged 18 to 65 years;
  • 2. HIV-infected patients who meet the diagnostic criteria of the Third Edition of HIV/AIDS Guidelines (2015 Edition);
  • 3. Baseline CD4 cell count >=200/ul;
  • 4. Start HAART time >=6 months;
  • 5. Good Compliance;
  • 6. Those who are willing to sign informed consent.

排除标准

  • 1. combined with opportunistic infections and other complications appear;
  • 2. merger severe cardiovascular and cerebrovascular, liver, kidney and hematopoietic diseases;
  • 3. psychiatric patients;
  • 4. pregnant and lactating women;
  • 5. receiving other treatments that may affect the efficacy of the test drug.

研究者

发起方
Sichuan Provincial Administration of Traditional Chinese Medicine

相似试验